Second edition

18.qxd 3/10/08 9:52 AM Page 595
Winkelmann J, Wetter TC, Collado-Seidel V et al. Clinical
characteristics of the hereditary restless legs syndrome in a
population of 300 patients. Sleep 2000; 23:597–602.
Winkelmann J, Muller-Myhsok B, Wittchen H-U et al. Complex
segregation analysis of restless legs syndrome provides
evidence of an autosomal dominant mode of inheritance in
early age at onset families. Ann Neurol 2002; 52:297–302.
Winkelmann JW, Sethi KD, Kushida CA et al. Efficacy and safety of
pramipexole in restless legs syndrome. Neurology 2006;
67:1034–9.
Wyatt JK. Delayed sleep phase syndrome: pathophysiology and
treatment options. Sleep 2004; 27:1195–203.
Xu Y, Padiath QS, Shapiro RE et al. Functional consequences of a
CKIdelta mutation causing familial advanced sleep phase
syndrome. Nature 2005; 434:640–4.
References 595
Yaggi HK, Concato J, Kernan WM et al. Obstructive sleep apnea as
a risk factor for stroke and death. N Engl J Med 2005;
353:2034–45.
Yang W, Dollear M, Muthukrishnan SR. One rare side effect of
zolpidem – sleepwalking: a case report. Arch Phys Med Rehabil
2005; 86:1265–6.
Zambelis T, Paparrigopoulos T, Soldatos CR. REM sleep behavior
disorder associated with a neurinoma of the left pontocerebellar
angle. J Neurol Neurosurg Psychiatry 2002; 72:821–2.
Zammit GK, McNabb LJ, Caron J et al. Efficacy and safety of
eszopiclone across 6 weeks of treatment for primary insomnia.
Curr Med Res Opin 2004; 20:1979–91.
Zhdanova IV, Wurtman RJ, Regan MM et al. Melatonin treatment
for age-related insomnia. J Clin Endocrincol Metabol 2001;
86:4727–30.